Craig Bijou
Stock Analyst at B of A Securities
(3.78)
# 556
Out of 5,178 analysts
70
Total ratings
61.54%
Success rate
51.59%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Downgrades: Underperform | $38 → $20 | $25.07 | -20.22% | 6 | Feb 26, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $82 → $92 | $71.54 | +28.60% | 3 | Jan 5, 2026 | |
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $86.50 | +5.20% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $6.49 | +38.67% | 2 | Jul 9, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $110.49 | +26.71% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $15.89 | +6.99% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $9.38 | +91.90% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $86.83 | +66.99% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $69.31 | +48.61% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $55.52 | +53.10% | 1 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $71.54 | +32.79% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $12.84 | +180.37% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $8.95 | +402.79% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $10.90 | +1,000.92% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $6.12 | +390.20% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $8.5 → $6.5 | $13.49 | -51.82% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $11.79 | +256.23% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $468.55 | -50.91% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $332.68 | -30.86% | 4 | Jul 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $10.05 | - | 3 | Dec 4, 2017 |
PROCEPT BioRobotics
Feb 26, 2026
Downgrades: Underperform
Price Target: $38 → $20
Current: $25.07
Upside: -20.22%
GE HealthCare Technologies
Jan 5, 2026
Maintains: Neutral
Price Target: $82 → $92
Current: $71.54
Upside: +28.60%
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $86.50
Upside: +5.20%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $6.49
Upside: +38.67%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $110.49
Upside: +26.71%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $15.89
Upside: +6.99%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $9.38
Upside: +91.90%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $86.83
Upside: +66.99%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $69.31
Upside: +48.61%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $55.52
Upside: +53.10%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $71.54
Upside: +32.79%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $12.84
Upside: +180.37%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $8.95
Upside: +402.79%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $10.90
Upside: +1,000.92%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $6.12
Upside: +390.20%
Mar 24, 2020
Reiterates: Overweight
Price Target: $8.5 → $6.5
Current: $13.49
Upside: -51.82%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $11.79
Upside: +256.23%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $468.55
Upside: -50.91%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $332.68
Upside: -30.86%
Dec 4, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $10.05
Upside: -